全文获取类型
收费全文 | 120042篇 |
免费 | 7251篇 |
国内免费 | 1590篇 |
专业分类
耳鼻咽喉 | 1593篇 |
儿科学 | 2997篇 |
妇产科学 | 4114篇 |
基础医学 | 18443篇 |
口腔科学 | 3618篇 |
临床医学 | 9405篇 |
内科学 | 22021篇 |
皮肤病学 | 2469篇 |
神经病学 | 8058篇 |
特种医学 | 4065篇 |
外国民族医学 | 3篇 |
外科学 | 16999篇 |
综合类 | 5241篇 |
一般理论 | 35篇 |
预防医学 | 8736篇 |
眼科学 | 2844篇 |
药学 | 10304篇 |
中国医学 | 832篇 |
肿瘤学 | 7106篇 |
出版年
2021年 | 1036篇 |
2019年 | 1103篇 |
2018年 | 1665篇 |
2017年 | 1201篇 |
2016年 | 1235篇 |
2015年 | 1483篇 |
2014年 | 1938篇 |
2013年 | 2505篇 |
2012年 | 3652篇 |
2011年 | 3931篇 |
2010年 | 2326篇 |
2009年 | 2098篇 |
2008年 | 3462篇 |
2007年 | 3688篇 |
2006年 | 3677篇 |
2005年 | 3240篇 |
2004年 | 3025篇 |
2003年 | 2816篇 |
2002年 | 2664篇 |
2001年 | 6757篇 |
2000年 | 6954篇 |
1999年 | 5727篇 |
1998年 | 1838篇 |
1997年 | 1388篇 |
1996年 | 940篇 |
1995年 | 867篇 |
1992年 | 3748篇 |
1991年 | 3822篇 |
1990年 | 3557篇 |
1989年 | 3563篇 |
1988年 | 3437篇 |
1987年 | 3299篇 |
1986年 | 3098篇 |
1985年 | 2980篇 |
1984年 | 2054篇 |
1983年 | 1792篇 |
1982年 | 987篇 |
1979年 | 1912篇 |
1978年 | 1184篇 |
1977年 | 988篇 |
1976年 | 920篇 |
1975年 | 1191篇 |
1974年 | 1361篇 |
1973年 | 1414篇 |
1972年 | 1357篇 |
1971年 | 1247篇 |
1970年 | 1137篇 |
1969年 | 1121篇 |
1968年 | 1024篇 |
1967年 | 897篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
J Thornton D M Ashcroft M Z Mughal R A Elliott T W O'Neill D Symmons 《Archives of disease in childhood》2006,91(9):753-761
AIMS: To evaluate the currently available evidence for the effectiveness of bisphosphonates in children with low bone mineral density (BMD) and fragility fractures associated with juvenile idiopathic arthritis (JIA), and the safety of bisphosphonates in JIA and other conditions. METHODS: Literature databases were searched using a structured search strategy. The effectiveness review included any studies of children with JIA treated with bisphosphonates. The safety review also included studies of osteogenesis imperfecta. Quantitative data analysis was not undertaken because of the heterogeneity of the studies; findings were summarised using tables and narrative synthesis. RESULTS: Ninety four studies were identified. Sixteen studies (78 JIA children) were included in the effectiveness review: one randomised controlled trial, three controlled cohort studies, 11 case series, and one case report. At baseline, children had low BMD below the expected values for age and sex matched children. In all studies, treatment with bisphosphonates increased BMD compared with baseline: the mean percentage increase in spine BMD ranged from 4.5% to 19.1%. Overall, studies were heterogeneous and of variable quality. A total of 59 papers were included in the safety review; treatment durations were up to three years. The most common side effect was a flu-like reaction with intravenous treatment. This occurred during the first infusion and was transient; the symptoms were managed with paracetamol and did not occur during subsequent cycles. CONCLUSIONS: Bisphosphonates are a promising treatment for low BMD and fragility fractures in children with JIA. However, the quality of the current evidence is variable and better studies are needed to more clearly assess their role. 相似文献
102.
This paper reports on 1330 infants, from birth to 24 months old, suffering from diarrhoea and moderate to severe dehydration who were hospitalized in Tehran University Hospital over a period of 11 months. Fifteen per cent of them had signs of shock and 36% had marasmus. All patients were treated orally in two phases: rehydration therapy and maintenance therapy. For rehydration, an isotonic fluid (sodium 80 mmol l-1, potassium 20 mmol l-1) was administered at a rate of 40 ml kg-1 h-1 until all signs of dehydration disappeared. Following complete hydration, the patients were discharged and maintenance therapy was performed at home, by mothers, administering Maintenance Solution (sodium 40 mmol l-1, potassium 30 mmol l-1) ad libitum. Intravenous fluids were not used, even in severe dehydration. The efficacy and safety of this regimen were confirmed by rapid and successful rehydration in 99.7% of the patients and correction of a wide variety of electrolyte abnormalities present on admission, though some relapsed. The study suggests that this protocol could be employed in varied types and severities of dehydration and electrolyte abnormalities, and could also be used in both well nourished infants and in those with severe marasmus. It also demonstrates that mothers can serve as effective health workers and can perform successful maintenance therapy. Nine per cent of treated children required readmission to hospital within 24 h of discharge and a further 8% were hospitalized elsewhere with recurrent symptoms. 相似文献
103.
104.
105.
H N Qian J Feng H Cui B S Gao S L Qin T Y Fu P Wei Z Y Fu S M Gao Z Y Yang 《中华医学杂志(英文版)》1991,104(2):109-113
Monoclonal antibody 131I-COC183B2, developed in our laboratory and proved to fit for human treatment was injected intraperitoneally or subcutaneously in 13 patients. In 8 cases with i.p. injection the disease corresponded with the image, i.e. 3 primary ovarian epithelial cancers showed positive images, 1 ovarian Krukenberg tumor was negative and the other 4 negative images included 1 uterine myoma and 3 ovarian teratomas. In the subcutaneous injection group, 4 cases had ovarian carcinoma, surgery and chemotherapy. Two negative images corresponded with the clinical status-in good health, another negative case had metastatic left supraclavicular lymph node due to ovarian mucinous adenocarcinoma. The last negative image in this group was a case of benign ovarian teratoma which was proved after surgery. The 1 positive case was waiting to be proved by a scheduled third operation. The computer scintigram calculation of T/NT was 5.35 to 13.7. The results suggest that this monoclonal antibody can be used for radioimmunoimaging for the localization of ovarian carcinoma, which is not only helpful for clinical staging and differential diagnosis but is also a good follow-up method.
相似文献
106.
107.
Zhang Gu-sheng章谷生 Hu Fang-yuan胡方远 Ye Qing-zhen叶庆祯 Yan Yong-tang严咏棠Immunology Laboratory Shanghai Institute of Biologicat Products Shanghai 《中华医学杂志(英文版)》1986,99(4):343-346
Neurotropin (NSP) is an extract isolated from
the skin of rabbits inoculated with vaccinia virus.
The present study examines the possible action of
NSP on the number and function of immunocompe
tent cells in mice. The experiment showed that NSP
had no effect on both T and B lymphocytes of nor-
malimmunized mouse spleen. The degree of plaque
forming cell reaction and titre of specific antibody
showed no significant differences when the NSP
treated group and controls were compared. How-
ever, NSP exhibited promotive effect on specific
antigen binding cells in the early stage of immune
responses. It was also noted that the rosette forming
capacity of human T lymphocytes in vitro was restor-
ed markedly by NSP. These results suggest that
NSP possesses certain immunostimulating activity,
particularly on the specific antigen binding cells and
human T lymphocytes. 相似文献
108.
A nuclear protein associated with human cancer cells binds preferentially to a human repetitive DNA sequence. 总被引:2,自引:1,他引:1
下载免费PDF全文
![点击此处可从《Proceedings of the National Academy of Sciences of the United States of America》网站下载免费的PDF全文](/ch/ext_images/free.gif)
M L Law J Z Gao T T Puck 《Proceedings of the National Academy of Sciences of the United States of America》1989,86(21):8472-8476
A protein (Rp66) of 66 kDa was shown by DNA-binding protein blot assay to bind to a human repetitive DNA sequence (low-repeat sequence; LRS) in each of 10 transformed human cell lines examined. This protein-DNA interaction was not observed in 11 normal human cell cultures or in the Chinese hamster cell line CHO-K1. Gel retardation assay confirmed the specificity of the protein-DNA binding between Rp66 and LRS. In a histiocytic lymphoma human cell line, U937, that can be induced to differentiate in the presence of phorbol ester, this binding disappeared after cell differentiation. These together with other results cited suggest a regulatory role for these repetitive sequences in the human genome, with particular application to cancer. 相似文献
109.
M Z Atassi M Yoshioka G S Bixler Jr 《Proceedings of the National Academy of Sciences of the United States of America》1989,86(17):6729-6733
Processing of a protein antigen into fragments is believed to be a prerequisite for its presentation by the antigen-presenting cell to the T cell. This model would predict that, in oligomeric proteins, T cells prepared with specificity for regions that are buried within subunit association surfaces should recognize the respective regions in vitro equally well on the isolated subunit or on the oligomer. Three hemoglobin (Hb) alpha-chain synthetic peptides, corresponding to areas that are situated either completely [alpha-(31-45)] or partially [alpha-(41-45) and alpha-(81-95)] within the interface between the alpha and beta subunits of Hb, and a fourth peptide representing a completely exposed area in tetrameric Hb were used as immunogens in SJL/J (H-2s) mice. Peptide-primed T cells were passaged in vitro with the respective peptide to obtain peptide-specific T-lymphocyte lines. T-cell clones were isolated from these lines by limiting dilution. T-cell lines and clones that were specific for buried regions in the subunit association surfaces recognized the free peptide and the isolated subunit but not the Hb tetramer. On the other hand, T cells with specificity against regions that are not involved in subunit interaction and are completely exposed in the tetramer recognized the peptide, the isolated subunit, and the oligomeric protein equally well. The responses of the T-cell lines and clones were major histocompatibility complex-restricted. Since the same x-irradiated antigen-presenting cells were employed, the results could not be attributed to differences or defects in Hb processing. The findings indicate that in vitro the native (unprocessed and undissociated) oligomeric protein was the trigger of major histocompatibility complex-restricted T-cell responses. 相似文献
110.
E. Wieczerzak E. Jankowska S. Rodziewicz‐Motowido A. Giedo J. giewka Z. Grzonka M. Abrahamson A. Grubb D. Brmme 《Chemical biology & drug design》2005,66(Z1):1-11
Abstract: We have designed and synthesized a new series of azapeptides which act as potential inhibitors of cathepsin B and/or cathepsin K. Their structures are based upon the inhibitory sites of natural cysteine protease inhibitors, cystatins. For the synthesized azapeptides, the equilibrium constants for dissociation of inhibitor–enzyme complex, Ki, were determined. Comparison of these values indicated that all of the azainhibitors act much stronger toward cathepsin B. Z‐Arg‐Leu‐His‐Agly‐Ile‐Val‐OMe ( 7 ) proved to be approximately 500 times more potent for cathepsin B than for cathepsin K. To be able to explain the obtained experimental values we used the molecular dynamics procedures to analyze the interactions between cathepsin B and compound 7 . We also determined the structure of the most potent and selective cathepsin B azainhibitor by means of NMR studies and theoretical calculations. In this report, we describe SAR studies of azapeptide inhibitors indicating the influence of the conformational flexibility of the examined compounds on inhibition of cathepsins B and K. 相似文献